[1]
2025. Formulation and Evaluation of Titanium Dioxide Nanoparticles encapsulating Enzalutamide for Sustained drug delivery. Journal of Carcinogenesis. 24, 8s (Oct. 2025), 458–467. DOI:https://doi.org/10.64149/J.Carcinog.24.8s.458-467.